# Two cases of pancreatic arteriovenous malformations treated with coil embolization via percutaneous transhepatic portal vein approach

**Authors:** Yu Sasaki, Hiroki Okada, Hiroto Imaimatsu, Kodai Hujihara, Kai Ishigaki, Takuji Araki

PMC · DOI: 10.1016/j.radcr.2025.09.038 · 2025-10-08

## TL;DR

Two patients with pancreatic arteriovenous malformations were successfully treated using a transhepatic portal vein embolization approach without arterial embolization.

## Contribution

A novel transhepatic portal vein embolization approach for treating pancreatic arteriovenous malformations is presented.

## Key findings

- Both patients showed successful outcomes with no adverse events during follow-up.
- In one case, no residual AVM was observed after treatment.
- Portal venous pressure significantly decreased in one patient after treatment.

## Abstract

Endovascular treatment for pancreatic arteriovenous malformation (P-AVM) has primarily involved transarterial approach. Here, we present two patients with P-AVMs, both of whom were treated using a percutaneous transhepatic portal vein approach in which coil embolization of the aneurysmal draining vein was conducted without arterial embolization. Contrast-enhanced computed tomography revealed a P-AVM with several feeding arteries and minimal veins, with Yakes types IIIa and IIIb presented in Cases 1 and 2, respectively. In Case 1, no residual AVM was observed. In Case 2, several residual feeding arteries were observed immediately post-embolization; however, they further reduced in number after 4 months. In Case 2, the portal venous pressure decreased from 22 mmHg to 14 mmHg. No adverse events were observed during the follow-up.

## Full-text entities

- **Diseases:** AVMs (MESH:C564254), AVM (MESH:D002538), P (MESH:D002972), P-AVM (MESH:D001165)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12546769/full.md

---
Source: https://tomesphere.com/paper/PMC12546769